214 related articles for article (PubMed ID: 28495863)
1. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
Drechsler C; Hayek SS; Wei C; Sever S; Genser B; Krane V; Meinitzer A; März W; Wanner C; Reiser J
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1265-1273. PubMed ID: 28495863
[TBL] [Abstract][Full Text] [Related]
2. Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.
Kopecky C; Genser B; Drechsler C; Krane V; Kaltenecker CC; Hengstschläger M; März W; Wanner C; Säemann MD; Weichhart T
Clin J Am Soc Nephrol; 2015 Feb; 10(2):224-31. PubMed ID: 25424990
[TBL] [Abstract][Full Text] [Related]
3. Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.
Hayek SS; Divers J; Raad M; Xu J; Bowden DW; Tracy M; Reiser J; Freedman BI
J Am Heart Assoc; 2018 May; 7(9):. PubMed ID: 29716888
[TBL] [Abstract][Full Text] [Related]
4. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
[TBL] [Abstract][Full Text] [Related]
5. Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney disease.
Lv L; Wang F; Wu L; Wang JW; Cui Z; Hayek SS; Wei C; Reiser J; He K; Zhang L; Chen M; Zhao MH
Nephrol Dial Transplant; 2020 Mar; 35(3):465-470. PubMed ID: 30124995
[TBL] [Abstract][Full Text] [Related]
6. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL
J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
[TBL] [Abstract][Full Text] [Related]
7. Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients.
Espe KM; Raila J; Henze A; Blouin K; Schneider A; Schmiedeke D; Krane V; Pilz S; Schweigert FJ; Hocher B; Wanner C; Drechsler C;
Clin J Am Soc Nephrol; 2013 Mar; 8(3):452-8. PubMed ID: 23335039
[TBL] [Abstract][Full Text] [Related]
8. Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
Saulnier PJ; Dieter BP; Tanamas SK; McPherson SM; Wheelock KM; Knowler WC; Looker HC; Meek RL; Nelson RG; Tuttle KR
Am J Nephrol; 2017; 46(4):276-284. PubMed ID: 28934744
[TBL] [Abstract][Full Text] [Related]
9. The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men.
Haugaard SB; Andersen O; Hansen TW; Eugen-Olsen J; Linneberg A; Madsbad S; Olsen MH; Jørgensen T; Borch-Johnsen K; Jeppesen J
Diabet Med; 2012 Apr; 29(4):479-87. PubMed ID: 22050462
[TBL] [Abstract][Full Text] [Related]
10. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses.
Williams ME; Lacson E; Wang W; Lazarus JM; Hakim R
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1595-601. PubMed ID: 20671217
[TBL] [Abstract][Full Text] [Related]
11. Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children.
Weidemann DK; Abraham AG; Roem JL; Furth SL; Warady BA
Am J Kidney Dis; 2020 Aug; 76(2):194-202. PubMed ID: 31987488
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy-associated plasma protein A associates with cardiovascular events in diabetic hemodialysis patients.
Kalousová M; Zima T; Krane V; März W; Wanner C; Tesař V; Drechsler C;
Atherosclerosis; 2014 Oct; 236(2):263-9. PubMed ID: 25108075
[TBL] [Abstract][Full Text] [Related]
13. Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.
Samman Tahhan A; Hayek SS; Sandesara P; Hajjari J; Hammadah M; O'Neal WT; Kelli HM; Alkhoder A; Ghasemzadeh N; Ko YA; Aida H; Gafeer MM; Abdelhadi N; Mohammed KH; Patel K; Arya S; Reiser J; Vaccarino V; Sperling L; Quyyumi A
Atherosclerosis; 2017 Sep; 264():108-114. PubMed ID: 28728756
[TBL] [Abstract][Full Text] [Related]
14. Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.
Nikorowitsch J; Borchardt T; Appelbaum S; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M
J Am Heart Assoc; 2020 Apr; 9(8):e015452. PubMed ID: 32299288
[TBL] [Abstract][Full Text] [Related]
15. Good glycemic control is associated with better survival in diabetic patients on peritoneal dialysis: a prospective observational study.
Yoo DE; Park JT; Oh HJ; Kim SJ; Lee MJ; Shin DH; Han SH; Yoo TH; Choi KH; Kang SW
PLoS One; 2012; 7(1):e30072. PubMed ID: 22291903
[TBL] [Abstract][Full Text] [Related]
16. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
[TBL] [Abstract][Full Text] [Related]
17. Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease.
Drechsler C; Kalim S; Wenger JB; Suntharalingam P; Hod T; Thadhani RI; Karumanchi SA; Wanner C; Berg AH
Kidney Int; 2015 Jun; 87(6):1201-8. PubMed ID: 25671766
[TBL] [Abstract][Full Text] [Related]
18. Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events.
Sehestedt T; Lyngbæk S; Eugen-Olsen J; Jeppesen J; Andersen O; Hansen TW; Linneberg A; Jørgensen T; Haugaard SB; Olsen MH
Atherosclerosis; 2011 May; 216(1):237-43. PubMed ID: 21354571
[TBL] [Abstract][Full Text] [Related]
19. Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.
Luo S; Coresh J; Tin A; Rebholz CM; Chen TK; Hayek SS; Tracy M; Lipkowitz MS; Appel LJ; Levey AS; Inker LA; Reiser J; Grams ME
Clin J Am Soc Nephrol; 2018 Jul; 13(7):1013-1021. PubMed ID: 29903900
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric dimethylarginine, race, and mortality in hemodialysis patients.
Drew DA; Tighiouart H; Scott T; Kantor A; Fan L; Artusi C; Plebani M; Weiner DE; Sarnak MJ
Clin J Am Soc Nephrol; 2014 Aug; 9(8):1426-33. PubMed ID: 24970872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
